SUNNYVALE, Calif., April 29, 2011 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a clinical stage biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer and immune mediated diseases, today announced that senior management will host a conference call and live audio webcast on Wednesday, May 4th, at 4:30 pm ET to discuss the company’s third quarter fiscal 2011 financial and operational results.
Conference Call and Webcast Details: | |
Date: Wednesday, May 4, 2011 | |
Time: 4:30 pm ET | |
Listen via Internet: http://ir.pharmacyclics.com/events.cfm | |
Toll-free: +1-877-407-8133 | |
International: +1-201-689-8040 | |
The webcast replay will be available for 30 days on the Investor Relations section of the company’s Web site at www.pharmacyclics.com.
About Pharmacyclics
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.
Presently, Pharmacyclics has four product candidates in clinical development and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.
The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.
Ramses Erdtmann
Vice President of Finance
Phone: 408-215-3325
SOURCE Pharmacyclics, Inc.
